Skip to main content

Postexposure Prophylaxis for Occupational Exposure and Sexual Assault

  • Chapter
AIDS in Africa

Conclusion

Randomized studies of PEP cannot be carried out for ethical and practical reasons. There are, however, many arguments supporting the use of anti-HIV PEP following ABE or sexual assault. States and health systems in resource-poor countries face the challenge of guaranteeing exposed HCWs and rape victims full-time and free-of-charge access to a physician capable of conducting a risk assessment, PEP drugs, and technical facilities for biologic assessment and serologic monitoring. Nonetheless, the use of HIV PEP in African countries must be supported and increased. Such efforts however, must also include the support and assurance of exposure prevention practices and a reduction in ABE incidence in health care settings. Likewise, efforts to reduce sexual violence worldwide must be stepped up.

While the number of occupationally infected HCWs is not in itself a public health crisis in comparison with the growing number of infections in the general population in Africa, ABE is a public health issue, as is the fear of occupational infection faced by ill-paid, ill-protected, and overworked HCWs in resource-poor countries. Providing prevention training, support, and free access to PEP is an ethical and fair measure that will help support HCWs in Africa in their continuing effort to provide quality care to an increasing number of HIV-infected patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Veeken H, Verbeek J, Houweling H, et al. Occupational HIV infection and health care workers in the tropics. Trop Doct, 1991;21:28–31.

    PubMed  CAS  Google Scholar 

  2. de Graaf R, Houweling H, van Zessen G. Occupational risk of HIV among western health care professionals posted in AIDS endemic areas. AIDS Care, 1998;10:441–452.

    Article  PubMed  Google Scholar 

  3. Consten EC, van Lanschot JJ, Henny PC, et al. A prospective study on the risk of exposure to HIV during surgery in Zambia. AIDS, 1995;9:585–588.

    PubMed  CAS  Google Scholar 

  4. Mann JM, Francis H, Quinn TC, et al. HIV sero-prevalence among hospital workers in Kinshasa, Zaire: lack of association with occupational exposure. JAMA, 1986;256:3099–3102.

    PubMed  CAS  Google Scholar 

  5. N’Galy B, Ryder RW, BilaK, et al. Human immunodeficiency virus infection among employees in an African hospital. N Engl J Med, 1988;319:1123–1127.

    Google Scholar 

  6. Habitnana P, Bullterys M, Usabuwera P, et al. A survey of occupational blood contacts and HIV infection among traditional birth attendants in Rwanda. AIDS, 1994;8:701–704.

    Google Scholar 

  7. Diakhaté M, Diallo I, Sow PS, et al. Risques de transmission du VIH chez Jes accoucheuses traditionnelles au Sénégal. In: Abstracts of the Xth International Conference on AIDS and STDs in Africa; December 7–11, 1997; bidjan, Côte d’Ivoire. Abstract B245.

    Google Scholar 

  8. Du Plessis R, Webber L, Saymaan Q. Bloodborne viruses in forensic medical practice in South Africa. Am J Forensic Med Pathol, 1999;20:364–368.

    PubMed  Google Scholar 

  9. Henderson DK, Fahey BJ, Willy M, et al. Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures: a prospective evaluation. Ann Intern Med, 1990;113:740–746.

    PubMed  CAS  Google Scholar 

  10. Public Health Laboratory Service. AIDS and STD at the Communicable Disease Surveillance Centre. Occupational transmission of HIV: Summary of published reports to June 1999. Public Health Laboratory Service, 1999:9–11.

    Google Scholar 

  11. Cardo DM, Culver DH, Ciesielski CA, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med, 1997;337:1485–1490.

    Article  PubMed  CAS  Google Scholar 

  12. Gumudoka B, Favot I, Berege ZA, et al. Occupational exposure to the risk of HIV infection among health care workers in Mwanza Region, United Republic of Tanzania. Bull World Health Org, 1997;75:133–140.

    Google Scholar 

  13. Adegboye AA, Moss GB, Soyinka F, et al. The epidemiology of needlestick and sharp instrument accidents in a Nigerian hospital. Infect Control Hosp Epidemiol, 1994; 15:27–31.

    Article  PubMed  CAS  Google Scholar 

  14. Abiteboul D, Antona D, Fourrier A, et al. GERES. Exposition accidentelle au sang du personnel soignant. Resultats d’un an de surveillance du risque pour les infirmieres dans 17 hopitaux. Pathol Biol (Paris), 1992;40:983–989.

    CAS  Google Scholar 

  15. Johanet H, Antona D, Bouvet E, et le GERES. Risques d’exposition accidentelle au sang au bloc operatoire, Résultats d’une étude prospective multicentrique. Ann Chir, 1995;49:403–410.

    PubMed  CAS  Google Scholar 

  16. Malachy O. Evaluation of a training workshop on HIV/AIDS for health care workers in Enugu and Anambra States of Nigeria. In: Abstracts of the Xth International Conference on AIDS and STDs in Africa; December 7–11, 1997; Abidjan, Côte d’Ivoire. Abstract B246.

    Google Scholar 

  17. Berkley S. Parenteral transmission of HIV in Africa. AIDS, 1991;5(Suppl 1):S87–S92.

    PubMed  Google Scholar 

  18. Birungi H. Injections and self-help: risk and trust in Ugandan health care. Soc Sci Med, 1998;47:1455–1462.

    Article  PubMed  CAS  Google Scholar 

  19. Sagoe-Moses C, Pearson RD. Risks to health care workers in developing countries. N Engl J Med, 2001;345:538–541.

    Google Scholar 

  20. Simonsen L, Kane A, Lloyd J, et al. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull World Health Org, 1999;77:789–800.

    PubMed  CAS  Google Scholar 

  21. Van de Perre P, Diakhate L, Watson-Williams J. Prevention of blood-borne transmission of HIV. AIDS, 1997;11(Suppl B):S89–S98.

    PubMed  Google Scholar 

  22. Wyatt HV The popularity of infections in the third world: origins and consequences for poliomyelitis. Soc Sci Med, 1984;19:911–915.

    Article  PubMed  CAS  Google Scholar 

  23. Mast ST, Woolwine JD, Gerberding JL. Efficacy of gloves in reducing blood volumes transferred during simulated needlestick injury. J Infec Dis, 1993;168:1589–1592.

    CAS  Google Scholar 

  24. Bennett NT, Howard RJ. Quantity of blood inoculated in a needlestick injury from suture needles. JAm CollSurg, 1994;178:107–110.

    CAS  Google Scholar 

  25. Puro V, Petrosillo N, Ippolito G, et al. Update on occupational HCV infection incidence studies. In: Program and Abstracts of the International Colloquium on Bloodborne Infections; June 8, 1995; Paris, France. International Social Security Association Section for Health Services, 1995. Abstract PA8.

    Google Scholar 

  26. Alter HJ, Seeff LB, Kaplan PM, et al. Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure. N Engl J Med, 1976;295:909–913.

    PubMed  CAS  Google Scholar 

  27. Grady GF, Lee VA, Prince AM, et al. Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial. J Infect Dis, 2002; 138:625–638.

    Google Scholar 

  28. Seeff LB, Wright EC, Zimmerman HJ, et al. Type B hepatitis after needle-stick exposures: Prevention with hepatitis B immune globulin: Final report of the Veteran’s Administration Cooperative Study. Ann Intern Med, 1978;88:285–293.

    PubMed  CAS  Google Scholar 

  29. Gilks CF, Wilkinson D. Reducing the risk of nosocomial HIV infection in British health workers working overseas: role of post-exposure prophylaxis. BMJ, 1998;316:1158–1160.

    PubMed  CAS  Google Scholar 

  30. Sow PS, Rachline A, Tarantola A, et al. pour les Correspondants du Réseau AES 3 Pays et le GERES. Connaissances et Practiques á Risque d’Accident Exposant au Sang (AES) chez les Soignants en Médecine dans 3 Pays d’Afrique de l’Ouest. Oral Presentation at the 12th International Conference on AIDS and STDs in Africa; December 8–13, 2001; Ouagadougou, Burkina Faso. Abstract 12BT3-4.

    Google Scholar 

  31. Centers for Disease Control and Prevention. Evaluation of blunt suture needles in preventing percutaneous injuries among health care workers during gynecologic surgical procedures—New York City, March 1993–June 1994. MMWR, 1997;46:25–29.

    Google Scholar 

  32. Gerberding JL, Littell C, Tarkington A, et al. Risk of exposure of surgical personnel to patients’ blood during surgery at San Francisco General Hospital. N Engl J Med, 1990;322:1788–1793.

    Article  PubMed  CAS  Google Scholar 

  33. Wright J, McGeer AJ, Chyatte D, et al. Mechanisms of glove tears and sharp injuries among surgical personnel. JAMA, 1991;266:1668–1671.

    PubMed  CAS  Google Scholar 

  34. Matta H, Thompson AM, Rainey JB. Does wearing two pairs of gloves protect operating theater staff from skin contamination? BMJ, 1988;297:597–598.

    Article  PubMed  CAS  Google Scholar 

  35. Diarra J, Msellati P, Brissac M, et al. SIDA et personnel soignant en Côte d’Ivoire. Med Trop, 1996;56:259–263.

    CAS  Google Scholar 

  36. Russi M, Hajdun M, Barry M. A program to provide antiretroviral prophylaxis to health care personnel working overseas. JAMA, 2000;283:1292–1293.

    Article  PubMed  CAS  Google Scholar 

  37. N’Dri A, Boka Yao A, Ouattara Y, et al. Les accidents exposant au sang (AES) en milieu de soins: évaluation et prise en charge. In: Abstracts of the Xth International Conference on AIDS and STDs in Africa; December 7–11, 1997; Abidjan, Côte d’Ivoire. Abstract B969.

    Google Scholar 

  38. Gamester CF, Tilzey AJ, Banatvala JE. Medical students’ risk of infection with bloodborne viruses at home and abroad: questionnaire survey. BMJ, 1999;318:158–160.

    PubMed  CAS  Google Scholar 

  39. Mastro TD, De Vincenzi I. Probabilities of sexual HIV-1 transmission. AIDS, 1996;10(Suppl A):S75–S82.

    PubMed  Google Scholar 

  40. Downs A, De Vincenzi I, and the European study group in heterosexual transmission of HIV Probability of heterosexual transmission of HIV: relationship to the number of unprotected sexual contacts. J AIDS, 1996; 11:388–395.

    CAS  Google Scholar 

  41. Duerr A, Xia Z, Nagachinta T, et al. Probability of male-to-female HIV transmission among married couples in Chiang Maï, Thaïland. In: Abstracts of the Xth International Conference on AIDS; August 7–12, 1994; Yokohama, Japan. Abstract 105C.

    Google Scholar 

  42. Cameron DW, Simonsen JN, D’Costa LJ, et al. Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet, 1989;ii:403–407.

    Google Scholar 

  43. Mastro TD, Satten GA, Nopkesorn T, et al. Probability of female-to-male transmission of HIV-1 in Thailand. Lancet, 1994;343:852–853.

    Article  Google Scholar 

  44. DeGruttola V Seage GR, Mayer KH, et al. Infectiousness of HIV between male homosexual partners. J Clin Epidemiol, 1989;42:849–856.

    Article  PubMed  CAS  Google Scholar 

  45. Vittinghoff E, Buchbinder SP, Judson F, et al. Percontact risk for transmission of HIV associated with four types of homosexual contact. In: Abstracts of the Vth Conference on Retroviruses and Opportunistic Infections; February 1–5, 1998; Chicago, IL, USA. Abstract 140.

    Google Scholar 

  46. Pantaleo G, Graziosi C, Fauci AS. The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med, 1993;328:327–335.

    Article  PubMed  CAS  Google Scholar 

  47. Tindall B, Evan L, Cunningham P, et al. Identification of HIV-1 in semen following primary HIV-1 infection. AIDS, 1992;6:949–952.

    PubMed  CAS  Google Scholar 

  48. Saag MS, Grain MJ, Decker WD, et al. High-level viremia in adults and children infected with immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels. J Infect Dis, 1991;164:72–80.

    PubMed  CAS  Google Scholar 

  49. Vernazza PL, Eron JJ, Cohen MS, et al. Detection and biologic characterization of infectious HIV-1 in semen of seropositive men. AIDS, 1994;8: 1325–1329.

    PubMed  CAS  Google Scholar 

  50. Vernazza PL, Gillian BL, Dyer J, et al. Quantification of HIV in semen: correlation with antiviral treatment and immune status. AIDS, 1997; 11:987–993.

    PubMed  CAS  Google Scholar 

  51. Royce RA, Sena A, Cates W, et al. Sexual transmission of HIV N Engl J Med, 1997;15:1072–1078

    Google Scholar 

  52. Halperin DT, Bailey RC. Male circumcision and HIV infection: 10 years and counting. Lancet, 1999;354:1813–1815.

    Article  PubMed  CAS  Google Scholar 

  53. Weiss H, Quigley M, Hayes R. Male circumcision and risk of infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS, 2000; 14:2361–2370.

    PubMed  CAS  Google Scholar 

  54. Buve A. Male circumcision and spread of HIV in sub-Saharan Africa. In: Abstracts of the XIII International AIDS Conference; July 9–14, 2000; Durban, South Africa. Abstract MoOrl92.

    Google Scholar 

  55. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and sexual transmission of human immunodeficiency virus type I. N Engl J Med, 2000; 342:921–929.

    Article  PubMed  CAS  Google Scholar 

  56. Dyer JR, Kazembe P, Vernazza PL, et al. High level of human immunodeficiency virus type 1 in blood and semen of seropositive men in sub-Saharan Africa. J Infect Dis, 1998; 177:1742–1746.

    Article  PubMed  CAS  Google Scholar 

  57. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect, 1999;75:3–17.

    Article  PubMed  CAS  Google Scholar 

  58. Bamberger JD, Waldo CR, Gerberding JL, et al. Postexposure prophylaxis for human immunodeficiency virus (HIV) infection following sexual assault. Am J Med, 1999; 106:323–327.

    Article  PubMed  CAS  Google Scholar 

  59. Ruprecht RM, Chou TC, Chipty F, et al. Interferon alpha and 3′ azido-3′ deoxythymidine are highly synergistic in mice and prevent viremia after acute retrovirus exposure. JAIDS, 1990;3:591–600.

    CAS  Google Scholar 

  60. Fazely F, Haseltine WA, Rodger RF, et al. Postexposure chemoprophylaxis with zidovudine or zidovudine combined with INF-α: failure after inoculating rhesus monkeys with a high dose of SIV. J AIDS, 1991;4:1093–1097.

    CAS  Google Scholar 

  61. Van Rompay KKA, Marthas ML, Ramos RA, et al. Simian immunodeficiency virus (SIV) infection of infant rhesus macaques as a model to test antiretroviral drug prophylaxis and therapy: oral 3′-azido-3′-deoxythymidine prevents SIV infection. Antimicrob Agents Chemother, 1992;36:2381–2386.

    PubMed  Google Scholar 

  62. Van Rompay KKA, Otsyula MG, Marthas ML, et al. Immediate zidovudine treatment protects simian immunodeficiency virus infected newborn macaques against rapid onset of AIDS. Antimicrob Agents Chemother, 1995;39:125–131.

    PubMed  Google Scholar 

  63. Tsai CC, Follis KE, Sabo A, et al. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl) adenine. Science, 1995;270:1197–1199.

    PubMed  CAS  Google Scholar 

  64. Lifson JD, Lloyd A, Hirsch V, et al. Clues to primate lentiviral pathogenesis from the study of SIV viral dynamics. Paper presented at: Retroviruses of human AIDS and related animal diseases: XI Colloque des cents gardes; October 27–29, 1997; Paris, France.

    Google Scholar 

  65. Tsai CC, Emau P, Follis KE, et al. Effectiveness of postinoculation(R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment. J Virol, 1998;72:4265–4273.

    PubMed  CAS  Google Scholar 

  66. Bottiger D, Johansson NG, Samuelsson B, et al. Prevention of SIV, SIVsm, or HIV-2 infection in cynomolgus monkeys by pre-and postexposure administration of BEA-005. AIDS, 1997;11:157–162.

    Article  PubMed  CAS  Google Scholar 

  67. Conner EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. NEnglJMed, 1994;331:1173–1180.

    Google Scholar 

  68. Sperling RS, Shapiro DE, Coombs RW, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. NEnglJMed, 1996;335:1621–1629.

    CAS  Google Scholar 

  69. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet, 1999;354:795–802.

    PubMed  CAS  Google Scholar 

  70. Perdue B, Wolderufael D, Mellors J, et al. HIV-1 transmission by a needlestick injury despite rapid initiation of four-drug postexposure prophylaxis. In: Abstracts of the 6th Conference on Retroviruses and Opportunistic Infections. January 31-February 4, 1999; Chicago, Illinois, USA. Abstract 210.

    Google Scholar 

  71. Lot F, de Benoist AC, Abiteboul D. Infections professionnelles par le VIH en France chez le personnel de santé—le point au 30 juin 1998. Bull Epid Hebd, 1999:18:69–70.

    Google Scholar 

  72. Centers for Disease Control and Prevention. Guidelines for the Prevention of Transmission of Human Immunodeficiency Virus and Hepatitis B Virus to Health-Care and Public Safety Workers. MMWR, 1989;38(Suppl 6):1–37.

    Google Scholar 

  73. Centers for Disease Control and Prevention. Evaluation of Safety Devices for Preventing Percutaneous Injuries Among Health Care Workers During Phlebotomy Procedures—Minneapolis-St. Paul, New York City, and San Francisco, 1993–1995. MMWR, 1997;46:21–25.

    Google Scholar 

  74. Henderson DK. Postexposure chemoprophylaxis for occupational exposures to the human immunodeficiency virus. JAMA, 1999;281:931–936.

    PubMed  CAS  Google Scholar 

  75. Clinical Effectiveness Group. National guideline for the management of adult victims of sexual assault. Sex Transm Inf, 1999;75(Suppl 1):S82–S84.

    Google Scholar 

  76. Bottomley CP, Sadler T, Welch J. Integrated clinical service for sexual assault victims in a genitourinary setting. SexTransmInf, 1999;75:116–119.

    CAS  Google Scholar 

  77. Jenny C, Hooton TM, Bowers A, et al. STDs in victims of rape. N Engl J Med, 1990;322:713–716.

    Article  PubMed  CAS  Google Scholar 

  78. Gostin LO, Lazzarini Z, Alexander D, et al. HIV test, counseling, and prophylaxis after sexual assault. JAMA, 1994;271:1436–1444.

    PubMed  CAS  Google Scholar 

  79. Doumbia S, Tarantola A, Bouvet E for the West African Accidental Blood Exposure Surveillance Network and the GERES. Implementation of prospective accidental blood exposure surveillance systems in three western African countries. In: Abstracts of the XIII International AIDS Conference; July 9–14, 2000; Durban, South Africa. Abstract TuPeD3652.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

Bouvet, E., Laporte, A., Tarantola, A. (2002). Postexposure Prophylaxis for Occupational Exposure and Sexual Assault. In: Essex, M., Mboup, S., Kanki, P.J., Marlink, R.G., Tlou, S.D., Holme, M. (eds) AIDS in Africa. Springer, Boston, MA. https://doi.org/10.1007/0-306-47817-X_37

Download citation

  • DOI: https://doi.org/10.1007/0-306-47817-X_37

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-46699-1

  • Online ISBN: 978-0-306-47817-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics